{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-004671","form_type":"8-K","ticker":null,"cik":"0001814140","company_name":"Apexigen, Inc.","filed_at":"2023-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.710580+00:00","generated_at":"2026-06-18T23:57:03.567308+00:00","sec_items":["2.05","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Apexigen cuts workforce 55%, engages Ladenburg Thalmann to explore strategic alternatives","bullets":["Workforce reduction of 55% (up to 11 of 20 employees) approved Feb 23, 2023; six positions eliminated by end of Feb, five by end of Apr.","Estimated costs: $1.1M in termination costs (Q1/Q2 2023) and $0.6M in retention costs (Q2/Q3 2023).","President/COO Francis Sarena and CFO William Duke each receive $150K cash and 150K RSUs as retention awards.","Engaged Ladenburg Thalmann as strategic advisor to evaluate sale, merger, divestiture, licensing, or other transactions.","No assurance of any transaction; company will not disclose developments until definitive agreement or otherwise determined."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-004671","json":"https://secwatch.observer/filing/0000950170-23-004671.json","markdown":"https://secwatch.observer/filing/0000950170-23-004671.md","text":"https://secwatch.observer/filing/0000950170-23-004671.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814140/000095017023004671/0000950170-23-004671-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814140/000095017023004671/apgn-20230223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:57:03.567308+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1250f2297d392fe9bcd4d93b694acf73cc61762","claim":"Apexigen, Inc. announced a restructuring with charges of approximately (i) $1.1 million in employee termination costs primarily related to severance costs, which are expected to be incurred in the first and second qua (55% of its workforce).","evidence_excerpt":"earlier termination, subject to certain exceptions. The total costs related to the Company’s cost-cutting measures and retention plan are estimated to be approximately (i) $1.1 million in employee termination costs primarily related to severance costs, which are expected to be incurred in the first and second quarters of 2023, and (ii) $0.6 million in employee","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1814140/000095017023004671/0000950170-23-004671-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately (i) $1.1 million in employee termination costs primarily related to severance costs, which are expected to be incurred in the first and second qua"},{"label":"Headcount","value":"55% of its workforce"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}